Gilead says Veklury should work against COVID-19 variants
pharmaphorum
JANUARY 22, 2021
The mutations identified in these new variants have not significantly altered the part of the virus that remdesivir targets or have any association with known mutations conferring reduced susceptibility of coronaviruses to remdesivir in vitro,” said Gilead in its statement. “We The UK strain – known as B.1.1.7
Let's personalize your content